Streetbeat News

Stock Prices

WING

Wingstop Inc reported Q3 FY23 sales growth of 26.4% YoY to $117.1 million, beating the analyst consensus estimate. System-wide sales, domestic same-store sales, and digital sales all saw significant increases. The company's board approved a quarterly dividend of $0.22 per share. Wingstop raised its FY23 domestic same-store sales growth outlook to about 16% from the previous 10% - 12% growth.

Portfolio Pulse from Shivani Kumaresan

November 01, 2023 | 5:20 pm

GSK

GSK's shares are trading lower after the company announced its Q3 earnings.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:19 pm

AMD

AMD reported better-than-expected Q3 financial results and issued guidance, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:18 pm

HUM

Humana's shares are trading lower after the company reported its Q3 earnings.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:18 pm

COUR

KBWB

LVS

The stock market is falling with the S&P 500 down more than 10% from its 2023 high due to inflation and government spending. Despite financial issues in China, Macau visitation is back at 2019 levels, which is positive for Las Vegas Sands ($LVS). Bank ETFs are predicting more bank failures, with the KBW Bank ETF ($KBWB) falling from $46 to $36. Gold and Bitcoin are rising while Treasuries are falling. 3Q GDP is up 4.9%, but this is seen as misleading. Coursera ($COUR) has had a great quarter, but its guidance is still conservative.

Portfolio Pulse from Gary Brode

November 01, 2023 | 5:18 pm

ACU

Shares of Acme United Corporation (ACU) have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:16 pm

MRK

Merck & Co Inc.'s stock has seen a 0.78% increase in the current session, trading at $103.50. Over the past month, the stock has increased by 1.31% and by 4.82% over the past year. The company's P/E ratio of 57.06 is higher than the aggregate P/E ratio of the Pharmaceuticals industry (26.91), indicating potential overvaluation or expected better performance.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 5:15 pm

SHC

Sotera Health reported mixed Q3 financial results and issued guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:15 pm

STVN

Jefferies has downgraded Stevanato's stock from Buy to Hold and reduced its price target from $39 to $29. This has led to a decrease in the trading price of Stevanato shares.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:13 pm

SMG

Scotts Miracle-Gro reported better-than-expected Q4 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:12 pm